收费全文 | 3306篇 |
免费 | 185篇 |
国内免费 | 10篇 |
耳鼻咽喉 | 60篇 |
儿科学 | 235篇 |
妇产科学 | 41篇 |
基础医学 | 393篇 |
口腔科学 | 53篇 |
临床医学 | 217篇 |
内科学 | 661篇 |
皮肤病学 | 102篇 |
神经病学 | 158篇 |
特种医学 | 119篇 |
外科学 | 501篇 |
综合类 | 162篇 |
预防医学 | 152篇 |
眼科学 | 126篇 |
药学 | 290篇 |
中国医学 | 15篇 |
肿瘤学 | 216篇 |
2023年 | 25篇 |
2022年 | 36篇 |
2021年 | 97篇 |
2020年 | 48篇 |
2019年 | 60篇 |
2018年 | 89篇 |
2017年 | 57篇 |
2016年 | 62篇 |
2015年 | 62篇 |
2014年 | 102篇 |
2013年 | 115篇 |
2012年 | 207篇 |
2011年 | 203篇 |
2010年 | 122篇 |
2009年 | 87篇 |
2008年 | 147篇 |
2007年 | 150篇 |
2006年 | 143篇 |
2005年 | 120篇 |
2004年 | 116篇 |
2003年 | 88篇 |
2002年 | 79篇 |
2001年 | 78篇 |
2000年 | 56篇 |
1999年 | 80篇 |
1998年 | 42篇 |
1997年 | 35篇 |
1996年 | 33篇 |
1995年 | 28篇 |
1994年 | 26篇 |
1993年 | 29篇 |
1992年 | 80篇 |
1991年 | 59篇 |
1990年 | 49篇 |
1989年 | 67篇 |
1988年 | 47篇 |
1987年 | 39篇 |
1986年 | 54篇 |
1985年 | 41篇 |
1984年 | 35篇 |
1983年 | 24篇 |
1981年 | 20篇 |
1979年 | 33篇 |
1977年 | 21篇 |
1976年 | 34篇 |
1975年 | 22篇 |
1972年 | 21篇 |
1971年 | 23篇 |
1970年 | 28篇 |
1969年 | 27篇 |
The aim of this study was to assess the level of AA-, ADP- and thrombin-mediated platelet reactivity in patients on aspirin before, during, and after major vascular surgery, which represents a model of on/off vascular inflammation. Firstly, we hypothesized, that in association with this inflammatory episode AA-, ADP- and thrombin-induced clotting would change in a dynamic manner. Secondly, that AA-induced clotting will be modified despite complete suppression of platelet TXB2 production by aspirin throughout the periprocedural period, possibly via a lipoxygenase-mediated mechanism.
Fourty patients underwent major vascular surgery (open abdominal aortic aneurysm operation, infrainguinal bypass for subcritical limb ischaemia or peripheral aneurysm repair with bypass). They were all on 75 mg of aspirin prior to and throughout the perioperative period and received 5000 units of unfractionated heparin intraoperatively. AA-, ADP-, and thrombin-induced clotting, AA metabolites (TXB2 and 12-Hyroxyeicosatetraenoic acid (12-HETE)) and inflammatory markers (CRP, IL-6, TNF-α and CD40) were measured pre-procedure and at 2, 24, 48 hours, 3 to 5 days and 3 months after surgery. AA-, ADP- and thrombin-induced platelet reactivity was assessed using thrombelastography. TXB2, 12-HETE, IL-6, TNF-α, CD40 were determined using the sequential competitive binding Enzyme-Linked ImmunoAssay technique and CRP was determined using an immune-turbidimetric test on human serum.
There was a transient rise in inflammatory markers in the early perioperative period (CRP at 24, 48 hours and 3 to 5 days p < 0.001 and IL-6 at 2, 24, 48 hours and 3 to 5 days p < 0.001 as compared to baseline). Patients had negligible levels of TXB2 throughout, confirming a consistent therapeutic response to aspirin. There was a transient rise in thrombin-mediated clotting (MAThrombin at 48 hours p = 0.001 and 3 to 5 days p < 0.001) and a fall in AA- and ADP-induced clotting in the early post op period (both MAAA and MAADP p = 0.001 at 2 hours). At 3 months, the level of AA- and ADP-induced clotting was significantly higher than at baseline (p = 0.008 for MAAA and p = 0.002 for MAADP), hence demonstrating a rebound effect.
These data demonstrate a novel dynamic variation in platelet aggregation with acute vascular inflammation, including AA-induced whole blood clotting which is apparently COX-1 independent. 相似文献
Fecal microbiota transplantation (FMT) is a highly effective therapy for recurrent Clostridioides difficile infection (CDI), with ~15% 1-year recurrence rate. Small studies have identified variable risk factors associated with FMT failure. We, therefore, performed a systematic review and meta-analysis to evaluate the predictors of FMT failure. A systematic search of Medline, Embase, and Web of Science was performed from January 2013 up to June 2020. Meta-analyses were performed using random-effects models and pooled adjusted odds ratios for risk factors reported in ≥2 studies were calculated. Overall, 2671 patients with recurrent CDI who underwent FMT in 12 studies were included. FMT failure occurred in 454 patients (16.9%) with median follow-up of 3 months (range 2–7.7 months). A total of 9 risk factors were identified in ≥2 studies. Meta-analysis showed that use of non- CDI antibiotics, presence of inflammatory bowel disease, poor quality of bowel preparation, CDI-related hospitalization before FMT, inpatient FMT, and severe CDI were associated with statistically significant increased risk of failure after FMT. Increasing age, female gender, and immunocompromised status were not associated with increased risk for FMT failure. Several risk factors (both modifiable and non-modifiable) are associated with FMT failure. Lower use of antibiotics in the post-FMT period and good bowel preparation at the time of FMT are associated with lower risk of failure after FMT. Additionally, patients with non-modifiable risk factors should be counseled to be particularly alert about recurrent symptoms after FMT.
相似文献